A part of Merck

407306 | γ-Interferon, Human, Recombinant, E. coli

407306
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Ver precios y disponibilidad
      Click To Print This Page

      Descripción

      Replacement Information

      Precios y disponibilidad

      Número de referenciaDisponiblidad Embalaje Cant./Env. Precio Cantidad
      US1407306-100UG
      Comprobando disponibilidad...
      Disponibilidad a confirmarDisponibilidad a confirmar
      En existencia 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente

          Frasco de vidrio 100 μg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          OverviewRecombinant, human γ-interferon expressed in E. coli. A multi-functional protein consisting of 144 amino acids. Exhibits antiviral and antitumor properties. Regulates the development of specific immune responses.
          Catalogue Number407306
          Brand Family Calbiochem®
          References
          ReferencesKohji, K., et al. 1994. J. Int. J. Cancer 58, 380.
          Kolb, J.P., et al. 1994. J. Biol. Chem. 269, 9811.
          Müller, U., et al. 1994. Science 264, 1918.
          Zahedi, K., et al. 1994. J. Biol. Chem. 269, 9669.
          Shuai, K., et al. 1993. Science 261, 1744.
          Wilson, K.C., and Finbloom, D.S. 1992. Proc. Natl. Acad. Sci. USA 89, 11964.
          Meager, A. 1987. Lymphokines and Interferons, A Practical Approach (Clemens, M.J., et al., eds.) p. 129, IRL Press, Oxford.
          Product Information
          FormLiquid
          FormulationSterile-filtered (0.22 µm) in 40 mM Tris-HCl, pH 7.4, carrier-free.
          Applications
          Biological Information
          Biological activityED₅₀ = 0.5-3.0 ng/ml as measured by inhibition (cytostasis) of human WiDr cells.
          Concentration Label Please refer to vial label for lot-specific concentration
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Dry Ice Only
          Toxicity Standard Handling
          Storage -20°C
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C). Do not store in glass vials without addition of carrier protein. Further dilute in low endotoxin medium or buffer containing FBS or tissue culture grade BSA.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Ficha datos de seguridad (MSDS)

          Título

          Ficha técnica de seguridad del material (MSDS) 

          Certificados de análisis

          CargoNúmero de lote
          407306

          Referencias bibliográficas

          Visión general referencias
          Kohji, K., et al. 1994. J. Int. J. Cancer 58, 380.
          Kolb, J.P., et al. 1994. J. Biol. Chem. 269, 9811.
          Müller, U., et al. 1994. Science 264, 1918.
          Zahedi, K., et al. 1994. J. Biol. Chem. 269, 9669.
          Shuai, K., et al. 1993. Science 261, 1744.
          Wilson, K.C., and Finbloom, D.S. 1992. Proc. Natl. Acad. Sci. USA 89, 11964.
          Meager, A. 1987. Lymphokines and Interferons, A Practical Approach (Clemens, M.J., et al., eds.) p. 129, IRL Press, Oxford.

          Folleto

          Cargo
          Growth Factors and Cytokines Technical Bulletin

          Citas

          Título
        • Sambit K. Nanda and Michael D. Baron. (2006) Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins. Journal of Virology 80, 7555-7568.
        • Phuong Thi Nguyen Sarkis, et al. (2006) STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-α. Journal of Immunology 177, 4530-4540.
        • Ficha técnica

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision05-June-2008 JSW
          DescriptionRecombinant, human γ-interferon expressed in E. coli. A multi-functional protein consisting of 144 amino acids. Exhibits antiviral and antitumor properties. Regulates the development of specific immune responses. Expressed in and purified from E. coli.
          FormLiquid
          FormulationSterile-filtered (0.22 µm) in 40 mM Tris-HCl, pH 7.4, carrier-free.
          Concentration Label Please refer to vial label for lot-specific concentration
          Biological activityED₅₀ = 0.5-3.0 ng/ml as measured by inhibition (cytostasis) of human WiDr cells.
          Storage -20°C
          Avoid freeze/thaw
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C). Do not store in glass vials without addition of carrier protein. Further dilute in low endotoxin medium or buffer containing FBS or tissue culture grade BSA.
          Toxicity Standard Handling
          Merck USA index14, 4992
          ReferencesKohji, K., et al. 1994. J. Int. J. Cancer 58, 380.
          Kolb, J.P., et al. 1994. J. Biol. Chem. 269, 9811.
          Müller, U., et al. 1994. Science 264, 1918.
          Zahedi, K., et al. 1994. J. Biol. Chem. 269, 9669.
          Shuai, K., et al. 1993. Science 261, 1744.
          Wilson, K.C., and Finbloom, D.S. 1992. Proc. Natl. Acad. Sci. USA 89, 11964.
          Meager, A. 1987. Lymphokines and Interferons, A Practical Approach (Clemens, M.J., et al., eds.) p. 129, IRL Press, Oxford.
          Citation
        • Sambit K. Nanda and Michael D. Baron. (2006) Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins. Journal of Virology 80, 7555-7568.
        • Phuong Thi Nguyen Sarkis, et al. (2006) STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-α. Journal of Immunology 177, 4530-4540.